Results 261 to 270 of about 12,784,255 (313)
Some of the next articles are maybe not open access.

Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX

Annals of the Rheumatic Diseases
Objectives Vacuoles, E1 enzyme, X-linked, autoinflammatory and somatic (VEXAS) syndrome is an adult-onset autoinflammatory disease associated with somatic ubiquitin-like modifier-activating enzyme 1 (UBA1) mutations. We aimed to evaluate the efficacy and
J. Hadjadj   +72 more
semanticscholar   +1 more source

Targeted photodynamic therapy

Lasers in Surgery and Medicine, 2006
AbstractBackground and ObjectivesPhotodynamic therapy (PDT) is an emerging modality for the treatment of various neoplastic and non‐neoplastic pathologies.Study Design/Materials and MethodsPDT usually occurs when reactive oxygen species (ROS) generated from light‐activated chemicals (photosensitizer, PS) destroy the target.
Nicolas, Solban   +2 more
openaire   +2 more sources

Psoriasis: Recent progress in molecular‐targeted therapies

Journal of dermatology (Print), 2021
Psoriasis is a multifactorial recalcitrant inflammatory skin disease characterized by bothersome scaly reddish plaques especially on frequently chafed body parts, such as the extensor sites of the extremities and scalp.
M. Honma, Kei Hayashi
semanticscholar   +1 more source

Targeted gene therapy

British Medical Bulletin, 1995
Melanin biosynthesis is limited to melanocytes partly as a consequence of transcriptional regulation of the enzymes involved in this pathway. Promoter sequences of these enzyme genes may be utilised to drive expression of complementary DNA coding for therapeutic genes so as to provide transcriptional targeting. We have used the 5'-flanking sequences of
I R, Hart, R G, Vile
openaire   +2 more sources

Chemotherapy and Targeted Therapy

2016
Salivary gland cancers are uncommon neoplasms of the head and neck that exhibit considerable pathological, biological, and clinical diversity, resulting in a paucity of prospective data regarding the use of non-surgical treatments. Chemotherapy has shown limited activity in patients with metastatic disease, and there has been little exploration of its ...
Mehmet, Sen, Robin, Prestwich
openaire   +2 more sources

Targeted therapies in melanoma

Cancer Treatment Reviews, 2006
In the last decade the incidence of melanoma has been rising. Despite this, survival remains substantially constant because early diagnosis of thin lesions has increased. By contrast, metastatic melanoma continues to have a poor prognosis and it still represents a challenge for oncologists. Response rates with single agent dacarbazine range from 10% to
Paola, Queirolo, Mirko, Acquati
openaire   +2 more sources

Targeted cancer therapies

Nature Reviews Drug Discovery, 2010
Oncology has become one of the major focus areas for pharmaceutical and biotechnology companies. In 2009, ~16,000 of the ~40,000 Phase I, II and III trials listed on ClinicalTrials.gov were related to cancer (~40%). This large interest stems from the existence of high unmet need for improved treatments of multiple types of cancer and the substantial ...
openaire   +2 more sources

Targeted cancer therapy

Nature, 2004
Disruption of the normal regulation of cell-cycle progression and division lies at the heart of the events leading to cancer. Complex networks of regulatory factors, the tumour microenvironment and stress signals, such as those resulting from damaged DNA, dictate whether cancer cells proliferate or die.
openaire   +2 more sources

A Trial of Targeted Therapy

International Journal of Radiation Oncology*Biology*Physics, 2021
International ...
openaire   +4 more sources

Targeted Therapy in Gliomas

Current Oncology Reports, 2014
The survival outcome of patients with malignant gliomas is still poor, despite advances in surgical techniques, radiation therapy and the development of novel chemotherapeutic agents. The heterogeneity of molecular alterations in signaling pathways involved in the pathogenesis of these tumors contributes significantly to their resistance to treatment ...
Mohamed Ali, Hamza, Mark, Gilbert
openaire   +2 more sources

Home - About - Disclaimer - Privacy